» Authors » Julie Traclet

Julie Traclet

Explore the profile of Julie Traclet including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 594
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Petitgrand L, Ahmad K, Gamondes D, Diesler R, Fabien N, Gallay L, et al.
J Clin Med . 2025 Jan; 14(1. PMID: 39797328
Antibodies against Ku have been described in patients with various connective tissue diseases. The objective of this study was to describe the clinical, functional, and imaging characteristics of interstitial lung...
2.
Guirriec Y, Luque-Paz D, Bernard G, Mabo A, Kerjouan M, Menard C, et al.
ERJ Open Res . 2024 Dec; 10(6). PMID: 39624377
Background: Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease that may progress towards pulmonary fibrosis. Data about fibrosis prevalence and risk factors are lacking. Methods: In this retrospective multicentre...
3.
Mansy L, Caille A, Reynaud-Gaubert M, Bermudez J, Bonniaud P, Borie R, et al.
Eur Respir J . 2024 Sep; 64(3. PMID: 39231630
No abstract available.
4.
Turquier S, Huot L, Lamkhioued M, Subtil F, Traclet J, Ahmad K, et al.
PLoS One . 2024 May; 19(5):e0298727. PMID: 38768104
Cardiac output (CO) is one of the primary prognostic factors evaluated during the follow-up of patients treated for pulmonary hypertension (PH). It is recommended that it be measured using the...
5.
Desaintjean C, Ahmad K, Traclet J, Gerfaud-Valentin M, Durel C, Glerant J, et al.
Front Med (Lausanne) . 2024 Apr; 11:1341310. PMID: 38585151
Introduction: Asthma associated with eosinophilic granulomatosis with polyangiitis (EGPA) is often severe and corticosteroid-dependent, leading to significant morbidity. Mepolizumab and benralizumab are humanized monoclonal antibodies targeting interleukin 5 (IL-5) and...
6.
Piliero N, Salvat M, Finas M, Curioz F, Traclet J, Ahmad K, et al.
ERJ Open Res . 2024 Mar; 10(2). PMID: 38444667
https://bit.ly/3vZZvib.
7.
Diesler R, Legendre M, Si-Mohamed S, Brillet P, Wemeau L, Manali E, et al.
Respirology . 2024 Feb; 29(4):312-323. PMID: 38345107
Background And Objective: Variants in surfactant genes SFTPC or ABCA3 are responsible for interstitial lung disease (ILD) in children and adults, with few studies in adults. Methods: We conducted a...
8.
Diesler R, Cottin V, Gallien Y, Turquier S, Traclet J, Ahmad K, et al.
Respir Med Res . 2023 Dec; 85:101071. PMID: 38141576
Background And Objective: Lymphangioleiomyomatosis (LAM) is a rare multicystic lung disease. Although a correlation between pulmonary function test (PFT) results and exercise capacity appears probable, it has not yet been...
9.
Mismetti V, Delavenne X, Montani D, Bezzeghoud S, Delezay O, Hodin S, et al.
Respir Res . 2023 Nov; 24(1):273. PMID: 37936223
Background: Interstitial lung disease (ILD) and pulmonary hypertension (PH) represent the major causes of mortality in systemic sclerosis (SSc). Patients with systemic sclerosis and combined PH and ILD (SSc-PH-ILD) generally...
10.
Mabo A, Borie R, Wemeau-Stervinou L, Uzunhan Y, Gomez E, Prevot G, et al.
Thorax . 2023 Sep; 79(1):68-74. PMID: 37758458
Background: Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease, predisposing to an increased risk of infection. A complete picture of these infections is lacking. Research Question: Describe the characteristics...